Researchers at Wake Forest University School of Medicine have developed a battery-free wearable patch that could help detect skin cancer earlier and more accurately, potentially saving lives by making ...
Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...
Mass General Brigham AI and the University of Wisconsin–Madison will help to refine the company's latest foundational MRI ...
Phase I Trial of Concurrent Twice-Weekly Recombinant Human Interleukin-12 Plus Low-Dose IL-2 in Patients With Melanoma or Renal Cell Carcinoma Purpose: Response of solid malignancies to therapy is ...
Radiology, like most physician specialties, is dealing with a labor shortage driven by burnout and an aging workforce. AI is often heralded as something that can help solve these workforce problems, ...
Melbourne researchers test a new AI tool that detects tiny lesions in children with epilepsy, leading to surgeries that leave ...
Xencor's clear cell renal cell carcinoma treatment demonstrated evidence of anti-tumor activity in a phase 1 trial.
Real-World Germline BRCA Testing, Poly(ADP-ribose) Polymerase Inhibitor Utilization, and Survival Outcomes in Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback